Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00056862
What this trial is testing

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 58
Post-approval studies (Phase 4)Study completedNCT01465191
What this trial is testing

Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section

Who this might be right for
Postoperative Pain
Columbia University 169
Large-scale testing (Phase 3)Study completedNCT03186313
What this trial is testing

Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C
Egyptian Liver Hospital 72
Post-approval studies (Phase 4)Study completedNCT00077636
What this trial is testing

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,469
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Large-scale testing (Phase 3)Study completedNCT01448044
What this trial is testing

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 152
Large-scale testing (Phase 3)Study completedNCT03090035
What this trial is testing

Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment

Who this might be right for
Hepatitis CHepatitis C Relapse
Sheikh Zayed Medical College 98
Testing effectiveness (Phase 2)Ended earlyNCT02956629
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 282
Not applicableStudy completedNCT05449080
What this trial is testing

Disorders of Sex Development (DSD) 46.XY in Three Siblings

Who this might be right for
Genotype
Universitas Padjadjaran 3
Large-scale testing (Phase 3)Ended earlyNCT06304883
What this trial is testing

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

Who this might be right for
Early Alzheimer's Disease
Alzheon Inc. 163
Large-scale testing (Phase 3)Study completedNCT02250807
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis CGenotype 4 Chronic Hepatitis C
Janssen R&D Ireland 40
Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Large-scale testing (Phase 3)Study completedNCT02496078
What this trial is testing

Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 207
Large-scale testing (Phase 3)Study completedNCT01544920
What this trial is testing

Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 737
Large-scale testing (Phase 3)Study completedNCT01289782
What this trial is testing

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 395
Large-scale testing (Phase 3)Study completedNCT01497834
What this trial is testing

Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 224
Testing effectiveness (Phase 2)Study completedNCT01909804
What this trial is testing

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

Who this might be right for
Hepatitis C
Gilead Sciences 323
Early research (Phase 1)Study completedNCT02116543
What this trial is testing

TD-6450 MAD Study in HCV Infected Subjects

Who this might be right for
Hepatitis CHCV
Theravance Biopharma 47
Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Post-approval studies (Phase 4)Ended earlyNCT00803309
What this trial is testing

Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients

Who this might be right for
Hepatitis C, Chronic
HepNet Study House, German Liverfoundation 99
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation